BTLS Biotalys NV
Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and other fungi in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN-4 targeting oomycetes in fruits and vegetables; BIOFUN-8 targeting altenaria in fruits, vegetables, and specialty crops; and BioIns-2 targeting key insect pests. The company was formerly known as Agrosavfe NV and changed its name to Biotalys NV in December 2019. Biotalys NV was incorporated in 2013 and is headquartered in Ghent, Belgium.…
Industry Peers
Agricultural InputsKey Statistics
About Biotalys (EBR: BTLS)
›
Biotalys (EBR: BTLS) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Agricultural Inputs industry, part of the Basic Materials sector, and reports about 37 employees.
The shares were at 1.700 EUR on 19 November 2026, down 63.3% over 52 weeks. Its 52-week range is 1.560 EUR to 4.950 EUR: the price is 65.7% below the high and 9.0% above the low.
Its market capitalisation is 77.26M EUR.
Biotalys reports return on equity of -130.2% and revenue down 40.4% year over year.
It holds more cash than debt, a net cash position of 10.80M EUR. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 4.700 EUR is 176.5% above the current price. The next earnings report is expected on 18 March 2027.